[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626361":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":36,"responsibleParty":53,"collaborators":12,"id":55,"slug":12,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":12,"enrollmentInfo":63,"targetDuration":12,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":38,"whyStopped":12,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","NO_INTERVENTION","No atropine",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Experimental","EXPERIMENTAL","Participant uses atropine eyedrops",[18],"Drug: Atropine 1%",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Atropine 1%","Subtraction of atropine eyedrops from post-operative treatment regimen",[14],[26],"Atropine",[28],{"name":29,"affiliation":5,"role":30},"Jay Stewart, MD","PRINCIPAL_INVESTIGATOR",[32],{"name":29,"role":33,"phone":34,"phoneExt":12,"email":35},"CONTACT","415-353-9635","eyestudy@ucsf.edu",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","San Francisco","California","94143","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-122.41942,37.77493,{"lat":48,"lon":47},[51],{"name":52,"role":33,"phone":34,"phoneExt":12,"email":35},"Jay Stewart",{"type":54,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100626361",false,"NCT07434635","APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes","APPRAISE","Inclusion Criteria:\n\n* patient undergoing vitrectomy surgery\n* able to give informed consent\n\nExclusion Criteria:\n\n* post-operative eyedrop regimens that include topical non steroidal anti-inflammatory medications\n* subjects with altered post-operative eyedrop schedule for enhanced inflammation control\n* documented allergy to atropine","ALL","18 Years",{"count":64,"type":65},62,"ESTIMATED","INTERVENTIONAL",[68],"PHASE4","The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.",[71],"Eye Disorders",[73,74],"atropine","eye surgery","2026-02-19",{"date":77,"type":78},"2026-02-25","ACTUAL",{"date":80,"type":65},"2026-02",{"date":82,"type":65},"2029-02",{"name":5,"class":6},1]